Zdrowie i gospodarka · 16/11/2000

FDA Proposes Enhanced Blood Safety Measures to Combat HCV Transmission

The Food and Drug Administration (FDA) is proposing new regulations to improve blood safety, requiring blood establishments to quarantine prior donations from donors with a history of hepatitis C virus (HCV) infection and notify transfusion recipients of increased risk, as part of its 'Blood Initiative' to enhance disease prevention and control.